WebRegular monitoring may subsequently be done in primary care on specialist advice or depending on the person's care plan. This may include: Body weight, or body mass index (BMI) - weekly for the first 6 weeks, then at 3 months. Thereafter every 12 months, or more often if the person is gaining weight rapidly. WebThis is a summary of the full UKTIS monograph for health care professionals and should not be used in isolation. The full UKTIS monograph and access to any hyperlinked related documents is available to health care professionals at www.toxbase.org.. If you have a patient with exposure to a drug or chemical and require assistance in making a patient …
Directorate of Chief Medical Officer
WebLithium — furosemide reduces lithium excretion, leading to an increased risk of lithium toxicity. Monitor concurrent use and adjust dose. Nonsteroidal anti-inflammatory drugs (NSAIDs) — NSAIDs may antagonize the diuretic effect of furosemide and increase the risk of nephrotoxicity. WebThe lithium treatment plan also includes sections on minimum monitoring requirements for established lithium treatment; side-effects; drug interactions; and psychiatric review. … danby full console 18 dishwasher
Guidelines for the management of patients on lithium
WebThe NICE recommendations for using lithium are summarised in Table 1. Table 1. Treatment decisions, advice and monitoring regarding the use of lithium in women who are planning a pregnancy, pregnant or in the postnatal period – recommendations from NICE. Lithium. WebBackground: Lithium is a highly effective agent for numerous psychiatric disorders but requires therapeutic monitoring because of its narrow therapeutic index. This article … WebCP05 - Prescribing and Monitoring of Lithium Therapy Approved by Drug and Therapeutics Committee: March 2024. Review Date: March 2024. Page 7 of 11. patients … birds rainforest